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Background: Bone marrow examination is an invaluable tool in the diagnosis of hematological and non-
hematological diseases. Referral is made based on the clinical evaluation followed by after analysis of CBC and 
peripheral film. 
Objective: This study aims at evaluating the spectrum of diseases diagnosed on bone marrow biopsy at a tertiary 
care hospital of Rawalpindi, Pakistan. 
Materials and Methods: This descriptive, cross-sectional study was carried out at the pathology department of 
Holy family hospital for a duration of 1 year after ethical approval from IRF. All 220 cases requiring bone marrow 
examination were included in the study by consecutive sampling technique. Variables such as age, gender, 
presenting complaints, examination findings, CBC, peripheral blood film, indications and diagnosis of bone 
marrow examination were noted. Data were analyzed using SPSS v22. 
Results: Mean age was 29.15±20.9 years. 117(53.2%) specimens were of males and 103(46.8%) were of females. 
Spectrum of hematological and non-hematological diseases found on bone marrow examination ranged from 
acute leukemia in 37(16.8%) to megaloblastic anemia in 29(13.1%).The relationship between indications of referral 
and diagnosis of bone marrow examination was found to be statistically significant showing that suspected 
diagnosis made by the clinician was same as the final diagnosis in many cases. Pancytopenia was found as the 
major indication in most diseases (32.7%). 
Conclusion: Bone marrow examination is a useful tool in ascertaining diagnosis of various hematological. 
Pancytopenia was found to be major indication whereas, acute leukemia and megaloblastic anemia were most 
common malignant and benign hematological disorders on bone marrow examination, respectively. 








Bone marrow examination is a detailed procedure for 
analyzing the pathologies of bone marrow samples 
obtained through bone marrow aspiration and biopsy 
(often termed as trephine biopsy). Bone marrow 
aspiration is utilized for obtaining specimens for 
cytological evaluation, with analysis being directed 
toward the assessment of morphology and for 
obtaining a differential cell count. It further allows the 
samples to be directed towards other specialized tests, 
such as cytogenetics, molecular studies, microbiologic 
cultures, immunohistochemistry, and flow 
cytometry.1,2 Bone marrow aspiration and biopsy is the 
most frequent and safe invasive procedure carried out 
in hospitals for the diagnosis of hematological and 
non- hematological diseases.3,4 The hematological 
diseases include acute leukemia, myeloproliferative 
disease (MPD), lymphoid neoplasm and various 
nutritional deficiency diseases whereas non-
hematological diseases include infectious diseases 
infiltrating the bone marrow such as tuberculosis, 
parasitic infections, metastatic deposits and metabolic 
storage diseases.5 Although a peripheral blood smear 
is carried out in patients with suspicion of 
hematological diseases, it alone does not reflect on the 
nature of disease process. Thus, a bone marrow biopsy 
is indicated based on the suspicion from clinical 
picture and peripheral blood smear.6 This study aims 
at evaluation the spectrum of diseases diagnosed on 
bone marrow biopsy at a tertiary care hospital of 
Rawalpindi, Pakistan. 
There is a wide spectrum of diseases revealing bone 
marrow changes. Majority of these disorders present 
with vague clinical symptoms and poses difficulty for 
clinicians in the diagnosis based on complete blood 
picture and peripheral film only; necessitating the use 
of bone marrow aspiration and examination for 
diagnosis.7 Rationale of the study is to ascertain the 
etiological spectrum of disorders on bone marrow 
examination which will guide the clinicians about the 
frequency of hematological and non-hematological 
disorders and their management in a clinical setup.  
 
Materials and Methods 
 
A descriptive cross-sectional study was conducted at 
the pathology department of Holy Family Hospital. 
All 220 cases requiring bone marrow examination for 
various hematological disorders were included in the 
study, from March 2016 to March 2017. Patients 
having contraindications for bone marrow aspirations 
such as skin infection at site of sample, osteomyelitis, 
active bleeding were excluded from study. Ethical 
approval was taken from the ethical review board 
before proceeding with data collection. The bone 
marrow examination was carried out in the group of 
patients who were referred to the pathology 
department because of unexplained anemia, 
pancytopenia, hematological malignancies, leukemia 
or thrombocytopenia. A detailed history, examination 
and all the relevant investigations were done. 
Peripheral blood smears, complete blood count and 
hematological parameters were performed prior to 
bone marrow aspiration. A written consent was taken 
from the patients by the concerned department. Bone 
marrow was collected by bone marrow aspiration 
needle under aseptic conditions after giving local 
anesthesia. An aspirate smear was prepared and 
stained. The slide was observed under the microscope 
and the findings were noted. 
Data were entered and analyzed using SPSS v22. 
Mean and standard deviation were calculated for 
quantitative variables. Frequencies and percentages 
were calculated for qualitative variables, such as for 
diagnosis and gender. A chi-square test of 
independence was applied to find out the association 
between indications of referral and diagnosis of bone 
marrow examination. The p-value to be considered 
statistically significant for the test was set at ≤ 0.05. A 
post-hoc comparison was further carried out between 
indications and hematological diseases with p-value 




A total of 220 patients, aged between 1 to 90 years, 
underwent bone marrow biopsy examination during 
the study period of 1 year,. Mean age was 29.15±20.9 
years. 117(53.2%) were male and 103(46.8%) were 
females with male to female ratio of 1.13:1. Major 
presenting complaints were fever in 159(72.3%), 
generalized weakness in 75(34.1%), dyspnea in 
46(20.9%), bleeding in 72(32.7%), and weight loss in 
27((12.3%) cases. Other minor presenting complaints 
included abdominal pain, vomiting, loose motion and 
body aches. On systemic examination, pallor was 
found in 168(76.3%), jaundice in 21(9.5%), 
lymphadenopathy in 41(18.6%), hepatomegaly in 
73(33.2%), splenomegaly in 95(43.2%), and bruises in 
34(15.5%). 
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The blood cell counts were highly variable (Table-I). 
On peripheral blood film examination, 24 had a 
normocytic normochromic picture, 38 had a microcytic 
hypochromic picture, 18 were macrocytic, and 140 had 
a dimorphic picture. The most frequent indications for 
which the patients were referred for bone marrow 
examination were pancytopenia in 113(51.3%), 
hematological malignancy in 53(24%) and anemia in 
32(14.5%) cases (see Figure-1). 86% of the specimens 
showed hypercellularity of bone marrow. The 
spectrum of hematological and non-hematological 
diseases as found on bone marrow examination 
ranged from acute leukemia in 37(16.8%), 
megaloblastic anemia in 29(13.1%) to some very rare 
diseases as Diamond Blackfan syndrome and Bernard-
Soulier syndrome in 1 specimen each (see Table-II). 
Among the 10 cases of patients suffering from anemia 
of chronic disease, 4 (40%) had a past history of 
tuberculosis. When examining the association between 
indications for which referral was made and definitive 
diagnosis on bone marrow examination, a chi-square 
test of independence revealed that the relationship 
between these variables was statistically significant 
χ2(112, N=220) = 264.9, p-value < .001. A post-hoc 
comparison was further carried out with p-value set as 
≤ .0004 by bonferroni correction. The results are shown 
in Table-III and Table-IV. The results show that the 
referral indication by the clinician based on complete 
blood count and peripheral blood film, was same as 
the final diagnosis of bone marrow examination in 
29.5% cases. Moreover, pancytopenia was found to be 
the major indication in most diseases (32.7%), 
commonest being in megaloblastic anemia, followed 
by aplastic anemia. 
 
Table-I Blood cell counts 
Blood Cell Indices 
(Normal Values) 
Minimum Value Maximum Value Mean 
TLC (4-11 x 103/µL) 0.40 328.7 25.9 
Hemoglobin (12-17 g/dL) 2.1 19.5 7.97 
Hematocrit (37.5-51%) 2.8 63.8 24.99 
Platelets (150-450 x 103/ µL) 2.0 1899.0 130.2 
 
 
Figure-1 Spectrum of diseases with indication for 
bone marrow examination-indications 
 
Table-II Hematological and non-hematological 
diseases on bone marrow examination 
A. Malignant hematological diseases (N=72/220) 















Multiple myeloma 1 (0.45%) 
B. Benign hematological diseases (N=138/220) 
Megaloblastic anemia 29 (13.1%) 
Iron deficiency anemia 5 (2.27%) 
Anemia of chronic 
disease 
10 (4.5%) 
Hemolytic anemia 15 (6.8%) 
Aplastic anemia 20 (9.09%) 
Peripheral destruction of 
platelets (itp) 
22 (10%) 
Hypersplenism 12 (5.45%) 
Reactive changes 16 (7.2%) 











C. Non- hematological diseases (N=10/220) 
Storage disorder 4 (1.81%) 
Visceral leishmaniases 6 (2.72%) 
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Table-III Diseases with indication of referral and definitive diagnosis on bone marrow examination 
Bone marrow diagnosis Indications for referral (p-value ≤ .0004) 
Hematological malignancies 
(AML, ALL, CML, CLL, MDS) 
Hematological Malignancy Pancytopenia Others 
42 (59.2 %) 24 (33.8 %) 5 (7%) 
Peripheral destruction of platelets  Thrombocytopenia  Others 
16 (72.7 %)  6 (27.3 %) 
Storage disorder Storage disorder Pancytopenia  
2 (50 %) 2 (50%)  
Polycythemia Polycythemia   
3 (100 %)   
Multiple myeloma Multiple myeloma   
1 (100 %)   
Diamond black fan syndrome Red cell aplasia   
1 (100 %)   
 
Table-IV Diseases with pancytopenia as the major 
indication of referral 
Hematological and non-
hematological diseases 
Pancytopenia as the 
major indication for 
referral 
Megaloblastic anemia 23 (79.3 %) 
Hypersplenism 12 (100 %) 
Visceral leishmaniases 4 (66.7 %) 
Fanconi's anemia 2 (100 %) 
Aplastic anemia 16 (80 %) 
Reactive changes 10 (62.5 %) 
Iron deficiency anemia 3 (60 %) 
Hemophagocytic 
syndrome 




Bone marrow examination is an important tool in 
diagnosis of various hematological and non-
hematological diseases.8,9 This study basically aimed at 
determining spectrum of diseases diagnosed on bone 
marrow examination and finding the most common 
indication of referral in our setup. A total of 220 
patients were included in our study with a male to 
female ratio of 1.13:1. Mean age was 29.15±20.9 years, 
compared to mean age of 38±2.33 years in another 
study.10 
Common clinical presentations were fever, 
generalized weakness, dyspnea, weight loss and 
bleeding manifestations. These were similar to the 
findings of the studies done by Prajapati et al and 
Belai et al.11,12 Pancytopenia has been one of the 
biggest diagnostic dilemmas for clinicians and 
presents as the most frequent indication (51.3%) for 
bone marrow examination in our study. Similar to 
this, pancytopenia was the major indication of referral 
in a study done by Pudasaini et al and Ghartimagar.3,13 
However, it was in contrast to the study from Saudi 
Arabia10, in which acute leukemia was the most 
common indication. Bone marrow was found to be 
hypercellular in most cases (86%), followed by 
hypocellular (12%) and normocellular (2%). This was 
similar to the study conducted by Pudaisani et al.3  
On bone marrow examination, benign hematological 
diseases (62.7%) comprised of most cases, followed by 
malignant hematological diseases (32.7%) and non-
hematological diseases (4.5%). This was similar to a 
study conducted by Gandapur et almand Meena, in 
which benign hematological diseases contributed to 
73.2% of all diagnoses.14,15 However, it was contrary to 
studies conducted in Saudi Arabia and India where 
malignant hematological diseases were the most 
common diagnosis (82.5%).10,16 Among the benign 
hematological diseases, megaloblastic anemia was the 
most frequent diagnosis observed, seen in 29 cases. 
Similarly, megaloblastic anemia was also the 
commonest condition (found in 37 cases) in a study 
conducted in Peshawar.17 In a study conducted in 
Khyber Pakhtunkhwa, hemolytic anemias were the 
commonest condition.18 In another study, 
megaloblastic anemia was the second most common 
diagnosis comprising of 16.6% of the cases.19 Among 
the malignant hematological diseases, the highest 
numbers of cases (34) were those of acute myeloid 
leukemia, followed by chronic myeloid leukemia. In 
another study, similar results were found, acute 
leukemia being the most prevalent hematological 
malignancy (34.6%) followed by chronic myeloid 
leukemia (28.8%).12 
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Our study showed that referral indication by the 
clinician based on complete blood count and 
peripheral blood film, was same as the final diagnosis 
of bone marrow examination in 29.5% of the cases. 
This shows that these investigations alone can lead to 
diagnosis in many cases. However, bone marrow 
examination is still necessary for the confirmation of 
final diagnosis. Moreover, it was found out that 
pancytopenia was the major indication in most 
diseases (32.7%), commonest being in megaloblastic 
anemia, followed by aplastic anemia, as shown in 
Table-IV. Likewise, the commonest cause for 
pancytopenia was megaloblastic anemia (79%) 
followed by aplastic anemia (18%) in a study 




Herein, indications of bone marrow examination were 
pancytopenia, followed by hematological 
malignancies. Spectrum of diagnosis at bone marrow 
examination ranged from malignant hematological 
diseases, benign hematological diseases to non-
hematological diseases like storage disorders and 
visceral leishmaniasis. Thus, our study concludes that 
bone marrow examination is an important diagnostic 
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